Comments submitted electronically, including attachments, to Regulations.gov will be posted to the docket unchanged
Acetylcysteine is used as a mucolytic agent in the adjunctive treatment of patients with abnormal, viscid, or inspissated mucous secretions in such conditions as acute and chronic bronchopulmonary disorders (e.g., pneumonia, bronchitis, emphysema, tracheobronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis, primary amyloidosis of the lung)
It belongs to the melanocortin family of peptides and is supplied strictly as a reference material for in-vitro and pre-clinical study
Each unit is freshly prepared to maintain peptide integrity and standardized dosing
Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines